Cancer/Tumor Profiling Market Analysis By Key Vendors, Segmentation, Region-wise Analysis Forecast To 2028
Cancer/tumor profiling technique provides genetic information in cancer cell. It also classifies tumors more accurately and helps oncologist to select appropriate therapy for the treatment of cancer. In case of breast cancer, tumor profiling may predict whether the cancer is more likely to recur. The immunohistochemistry (IHC) is a technology used to determine the level of protein expression in a tumor whereas, next-generation sequencing is used to examine and detect mutations in DNA sequences. Thus, the cancer/tumor profiling can avoid the over treatment of cancer patients.
Increasing number of cancer cases globally and increasing funding by several organizations for cancer research are major factors contributing to growth of the global cancer/tumor profiling market. In addition, rise in adoption of the cancer profiling methods by oncologist are other factors contributing to growth of the global cancer/tumor profiling market. Moreover, rising awareness about cancer globally, coupled with several governments and non-profit organizations providing education and support services, is anticipated to further drive growth of the global cancer/tumor profiling market over the forecast period.
A major factor restraining growth of the global cancer/tumor profiling market is high cost for development of biomarkers.
The global cancer/tumor profiling market report has been segmented on the basis of technologies, technique, application, and region. On the basis of region, the global cancer/tumor profiling market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Global cancer/tumor profiling market segmentation, by technology:
- Next-Generation Sequencing (NGS)
- Quantitative Polymerase Chain Reaction (QPCR)
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Fluorescence In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization (CISH)
Global cancer/tumor profiling market segmentation, by technique:
Global cancer/tumor profiling market segmentation, by application:
- Clinical Application
- Research Application
Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/cancer-tumor-profiling-market/request-sample/
North America market dominates the global cancer/tumor profiling market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel and increasing number of cancer cases in the region. Europe accounts for second-largest revenue share contribution to the global cancer/tumor profiling market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing investment by key market players in emerging market and increasing demand for advanced healthcare services.
Some prominent players in the global sterilization equipment market are Illumina, Inc., Qiagen N.V., Neogenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc., Caris Life Sciences, Helomics Corporation, Nanostring Technologies, Inc., Ribomed Biotechnologies, Inc., and Oxford Gene Technology